サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1420956

呼吸器系デバイス市場：世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年

Respiratory Devices Market (Product Type: Therapeutic Devices and Diagnostic & Monitoring Devices) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 274 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
呼吸器系デバイス市場：世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年
出版日: 2023年12月26日
発行: Transparency Market Research
ページ情報: 英文 274 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

呼吸器系デバイス市場- レポートの範囲

世界の呼吸器系デバイス市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、世界の呼吸器系デバイス市場の収益を提供し、2017年から2031年の期間、2023年を基準年、2031年を予測年とみなします。このレポートは、2023年から2031年までの世界の呼吸器系デバイス市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、呼吸器系デバイス市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 222億米ドル
2031年の市場価値 377億米ドル
CAGR 6.1%

このレポートは、世界の呼吸器系デバイス市場の競合情勢を詳しく調査しています。世界の呼吸器系デバイス市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の呼吸器系デバイス市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2017～2031年

第5章 重要な洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主な合併と買収
  • COVID-19のパンデミックが業界に与える影響

第6章 世界市場の分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：製品タイプ別、2017-2031
    • 治療用
    • 診断用・モニタリング用
  • 市場の魅力：製品タイプ別

第7章 世界市場の分析と予測：治療用デバイス別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：治療用デバイス別、2017-2031
    • ドラッグデリバリーデバイス
      • ネブライザー
      • 吸入器
    • 人工呼吸器
      • 侵襲的
      • 非侵襲的
    • CPAP
      • デバイス
      • 使い捨て用品
    • 蘇生器
      • 再利用可能
      • 使い捨て用品
    • 加湿器
    • 気道確保デバイス
    • 酸素濃縮器
    • 消耗品・使い捨て用品
    • その他
  • 市場の魅力：治療用デバイス別

第8章 世界市場の分析と予測：診断用・モニタリング用デバイス別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：診断用・モニタリング用デバイス、2017-2031
    • パルスオキシメーター
    • カプノグラフ
    • 肺活量計
    • 睡眠ポリグラフ
    • ピークフローメーター
    • ガス分析装置
    • その他
  • 市場の魅力：診断用・モニタリング用デバイス

第9章 世界市場の分析と予測：用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：用途別、2017-2031
    • 慢性閉塞性肺疾患
    • 喘息
    • 閉塞性睡眠時無呼吸
    • 呼吸窮迫症候群
    • 嚢胞性線維症
    • 肺炎
  • 市場の魅力：用途別

第10章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別、2017-2031
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第11章 北米市場の分析と予測

第12章 欧州市場の分析と予測

第13章 アジア太平洋市場の分析と予測

第14章 ラテンアメリカ市場の分析と予測

第15章 中東およびアフリカ市場の分析と予測

第16章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • ResMed
    • Koninklijke Philips NV
    • Vyaire Medical
    • Smiths Medical
    • Fisher &Paykel Healthcare Limited
    • Dragerwerk AG &Co.
    • GE Healthcare
    • Getinge AB
    • Medtronic plc
    • Chart Industries
図表

List of Tables

  • Table 01: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017-2031
  • Table 03: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017-2031
  • Table 05: Global Respiratory Devices Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 08: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017-2031
  • Table 9: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017-2031
  • Table 10: North America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 11: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 13: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017-2031
  • Table 14: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017-2031
  • Table 15: Europe Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 16: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 18: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017-2031
  • Table 19: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017-2031
  • Table 20: Asia Pacific Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 21: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017-2031
  • Table 24: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017-2031
  • Table 25: Latin America Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017-2031
  • Table 26: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 28: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Therapeutic Devices, 2017-2031
  • Table 29: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Diagnostic & Monitoring Devices, 2017-2031
  • Table 30: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast, by Application, 2017-2031

List of Figures

  • Figure 01: Global Respiratory Devices Market Size (US$ Mn), by Region, 2022 and 2031
  • Figure 02: Global Respiratory Devices Market Revenue (US$ Mn), by Product Type, 2022
  • Figure 03: Global Respiratory Devices Market Value Share, by Product Type, 2022
  • Figure 04: Global Respiratory Devices Market Revenue (US$ Mn), by Therapeutic Devices, 2022
  • Figure 05: Global Respiratory Devices Market Value Share, by Therapeutic Devices, 2022
  • Figure 06: Global Respiratory Devices Market Revenue (US$ Mn), by Diagnostic & Monitoring Devices, 2022
  • Figure 07: Global Respiratory Devices Market Value Share, by Diagnostic & Monitoring Devices, 2022
  • Figure 08: Global Respiratory Devices Market Revenue (US$ Mn), by Application, 2022
  • Figure 09: Global Respiratory Devices Market Value Share, by Application, 2022
  • Figure 10: Global Respiratory Devices Market Value Share, by Region, 2022
  • Figure 11: Global Respiratory Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 13: Global Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 14: Global Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
  • Figure 15: Global Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023-2031
  • Figure 16: Global Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
  • Figure 17: Global Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023-2031
  • Figure 18: Global Respiratory Devices Market Revenue (US$ Mn), by Application, 2022
  • Figure 19: Global Respiratory Devices Market Value Share, by Application, 2022
  • Figure 20: Global Respiratory Devices Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 21: Global Respiratory Devices Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America Respiratory Devices Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America Respiratory Devices Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 25: North America Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 26: North America Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
  • Figure 27: North America Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
  • Figure 28: North America Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 29: North America Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 30: North America Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023-2031
  • Figure 31: North America Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023-2031
  • Figure 32: North America Respiratory Devices Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 33: Europe Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 34: Europe Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 36: Europe Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 37: Europe Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
  • Figure 38: Europe Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
  • Figure 39: Europe Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 40: Europe Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 41: Europe Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023-2031
  • Figure 42: Europe Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023-2031
  • Figure 43: Europe Respiratory Devices Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 44: Asia Pacific Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 45: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 47: Asia Pacific Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 48: Asia Pacific Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
  • Figure 49: Asia Pacific Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
  • Figure 50: Asia Pacific Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 51: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 52: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023-2031
  • Figure 53: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023-2031
  • Figure 54: Asia Pacific Respiratory Devices Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 55: Latin America Respiratory Devices Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 56: Latin America Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Latin America Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 58: Latin America Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 59: Latin America Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
  • Figure 60: Latin America Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
  • Figure 61: Latin America Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 62: Latin America Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 63: Latin America Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023-2031
  • Figure 64: Latin America Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023-2031
  • Figure 65: Latin America Respiratory Devices Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 66: Middle East & Africa Respiratory Devices Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 67: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 68: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 69: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Product Type, 2022 and 2031
  • Figure 70: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Therapeutic Devices, 2022 and 2031
  • Figure 71: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Diagnostic & Monitoring Devices, 2022 and 2031
  • Figure 72: Middle East & Africa Respiratory Devices Market Value Share Analysis, by Application, 2022 and 2031
  • Figure 73: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Product Type, 2023-2031
  • Figure 74: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Therapeutic Devices, 2023-2031
  • Figure 75: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Diagnostic & Monitoring Devices, 2023-2031
  • Figure 76: Middle East & Africa Respiratory Devices Market Attractiveness Analysis, by Application, 2023-2031
目次
Product Code: TMRGL28073

Respiratory Devices Market - Scope of Report

TMR's report on the global respiratory devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global respiratory devices market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global respiratory devices market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the respiratory devices market.

Market Snapshot
Market Value in 2023US$ 22.2 Bn
Market Value in 2031US$ 37.7 Bn
CAGR6.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global respiratory devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global respiratory devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global respiratory devices market.

The report delves into the competitive landscape of the global respiratory devices market. Key players operating in the global respiratory devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global respiratory devices market profiled in this report.

Key Questions Answered in Global respiratory devices Market Report:

  • What is the sales/revenue generated by respiratory devices across all regions during the forecast period?
  • What are the opportunities in the global respiratory devices market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Respiratory Devices Market - Research Objectives and Research Approach

The comprehensive report on the global respiratory devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global respiratory devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global respiratory devices market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Respiratory Devices Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Respiratory Devices Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Respiratory Devices Market Analysis and Forecast, by Product Type

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. Therapeutic Devices
    • 6.3.2. Diagnostic & Monitoring Devices
  • 6.4. Market Attractiveness, by Product Type

7. Global Respiratory Devices Market Analysis and Forecast, by Therapeutic Devices

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Therapeutic Devices, 2017-2031
    • 7.3.1. Drug Delivery Devices
      • 7.3.1.1. Nebulizers
      • 7.3.1.2. Inhalers
    • 7.3.2. Mechanical Ventilators
      • 7.3.2.1. Invasive
      • 7.3.2.2. Non-invasive
    • 7.3.3. Continuous Positive Airway Pressure
      • 7.3.3.1. Devices
      • 7.3.3.2. Disposables
    • 7.3.4. Resuscitators
      • 7.3.4.1. Reusable
      • 7.3.4.2. Disposables
    • 7.3.5. Humidifiers
    • 7.3.6. Airway Clearance Devices
    • 7.3.7. Oxygen Concentrators
    • 7.3.8. Consumables & Disposables
    • 7.3.9. Others
    • 7.3.10. 7.4 Market Attractiveness, by Therapeutic Devices

8. Global Respiratory Devices Market Analysis and Forecast, by Diagnostic & Monitoring Devices

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017-2031
    • 8.3.1. Pulse Oximeters
    • 8.3.2. Capnographs
    • 8.3.3. Spirometers
    • 8.3.4. Polysomnographs
    • 8.3.5. Peak Flow Meters
    • 8.3.6. Gas Analyzers
    • 8.3.7. Others
  • 8.4. Market Attractiveness, by Diagnostic & Monitoring Devices

9. Global Respiratory Devices Market Analysis and Forecast, by Application

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Application, 2017-2031
    • 9.3.1. Chronic Obstructive Pulmonary Disease
    • 9.3.2. Asthma
    • 9.3.3. Obstructive Sleep Apnea
    • 9.3.4. Respiratory Distress Syndrome
    • 9.3.5. Cystic Fibrosis
    • 9.3.6. Pneumonia
  • 9.4. Market Attractiveness, by Application

10. Global Respiratory Devices Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Respiratory Devices Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. Therapeutic Devices
    • 11.2.2. Diagnostic & Monitoring Devices
  • 11.3. Market Attractiveness, by Product Type
  • 11.4. Market Value Forecast, by Therapeutic Devices, 2017-2031
    • 11.4.1. Drug Delivery Devices
      • 11.4.1.1. Nebulizers
      • 11.4.1.2. Inhalers
    • 11.4.2. Mechanical Ventilators
      • 11.4.2.1. Invasive
      • 11.4.2.2. Non-invasive
    • 11.4.3. Continuous Positive Airway Pressure
      • 11.4.3.1. Devices
      • 11.4.3.2. Disposables
    • 11.4.4. Resuscitators
      • 11.4.4.1. Reusable
      • 11.4.4.2. Disposables
    • 11.4.5. Humidifiers
    • 11.4.6. Airway Clearance Devices
    • 11.4.7. Oxygen Concentrators
    • 11.4.8. Consumables & Disposables
    • 11.4.9. Others
  • 11.5. Market Attractiveness, by Therapeutic Devices
  • 11.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017-2031
    • 11.6.1. Pulse Oximeters
    • 11.6.2. Capnographs
    • 11.6.3. Spirometers
    • 11.6.4. Polysomnographs
    • 11.6.5. Peak Flow Meters
    • 11.6.6. Gas Analyzers
    • 11.6.7. Others
  • 11.7. Market Attractiveness, by Diagnostic & Monitoring Devices
  • 11.8. Market Value Forecast, by Application, 2017-2031
    • 11.8.1. Chronic Obstructive Pulmonary Disease
    • 11.8.2. Asthma
    • 11.8.3. Obstructive Sleep Apnea
    • 11.8.4. Respiratory Distress Syndrome
    • 11.8.5. Cystic Fibrosis
    • 11.8.6. Pneumonia
  • 11.9. Market Attractiveness, by Application
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Product Type
    • 11.11.2. By Therapeutic Devices
    • 11.11.3. By Diagnostic & Monitoring Devices
    • 11.11.4. By Application
    • 11.11.5. By Country

12. Europe Respiratory Devices Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. Therapeutic Devices
    • 12.2.2. Diagnostic & Monitoring Devices
  • 12.3. Market Attractiveness, by Product Type
  • 12.4. Market Value Forecast, by Therapeutic Devices, 2017-2031
    • 12.4.1. Drug Delivery Devices
      • 12.4.1.1. Nebulizers
      • 12.4.1.2. Inhalers
    • 12.4.2. Mechanical Ventilators
      • 12.4.2.1. Invasive
      • 12.4.2.2. Non-invasive
    • 12.4.3. Continuous Positive Airway Pressure
      • 12.4.3.1. Devices
      • 12.4.3.2. Disposables
    • 12.4.4. Resuscitators
      • 12.4.4.1. Reusable
      • 12.4.4.2. Disposables
    • 12.4.5. Humidifiers
    • 12.4.6. Airway Clearance Devices
    • 12.4.7. Oxygen Concentrators
    • 12.4.8. Consumables & Disposables
    • 12.4.9. Others
  • 12.5. Market Attractiveness, by Therapeutic Devices
  • 12.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017-2031
    • 12.6.1. Pulse Oximeters
    • 12.6.2. Capnographs
    • 12.6.3. Spirometers
    • 12.6.4. Polysomnographs
    • 12.6.5. Peak Flow Meters
    • 12.6.6. Gas Analyzers
    • 12.6.7. Others
  • 12.7. Market Attractiveness, by Diagnostic & Monitoring Devices
  • 12.8. Market Value Forecast, by Application, 2017-2031
    • 12.8.1. Chronic Obstructive Pulmonary Disease
    • 12.8.2. Asthma
    • 12.8.3. Obstructive Sleep Apnea
    • 12.8.4. Respiratory Distress Syndrome
    • 12.8.5. Cystic Fibrosis
    • 12.8.6. Pneumonia
  • 12.9. Market Attractiveness, by Application
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Product Type
    • 12.11.2. By Therapeutic Devices
    • 12.11.3. By Diagnostic & Monitoring Devices
    • 12.11.4. By Application
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Respiratory Devices Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. Therapeutic Devices
    • 13.2.2. Diagnostic & Monitoring Devices
  • 13.3. Market Attractiveness, by Product Type
  • 13.4. Market Value Forecast, by Therapeutic Devices, 2017-2031
    • 13.4.1. Drug Delivery Devices
      • 13.4.1.1. Nebulizers
      • 13.4.1.2. Inhalers
    • 13.4.2. Mechanical Ventilators
      • 13.4.2.1. Invasive
      • 13.4.2.2. Non-invasive
    • 13.4.3. Continuous Positive Airway Pressure
      • 13.4.3.1. Devices
      • 13.4.3.2. Disposables
    • 13.4.4. Resuscitators
      • 13.4.4.1. Reusable
      • 13.4.4.2. Disposables
    • 13.4.5. Humidifiers
    • 13.4.6. Airway Clearance Devices
    • 13.4.7. Oxygen Concentrators
    • 13.4.8. Consumables & Disposables
    • 13.4.9. Others
  • 13.5. Market Attractiveness, by Therapeutic Devices
  • 13.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017-2031
    • 13.6.1. Pulse Oximeters
    • 13.6.2. Capnographs
    • 13.6.3. Spirometers
    • 13.6.4. Polysomnographs
    • 13.6.5. Peak Flow Meters
    • 13.6.6. Gas Analyzers
    • 13.6.7. Others
  • 13.7. Market Attractiveness, by Diagnostic & Monitoring Devices
  • 13.8. Market Value Forecast, by Application, 2017-2031
    • 13.8.1. Chronic Obstructive Pulmonary Disease
    • 13.8.2. Asthma
    • 13.8.3. Obstructive Sleep Apnea
    • 13.8.4. Respiratory Distress Syndrome
    • 13.8.5. Cystic Fibrosis
    • 13.8.6. Pneumonia
  • 13.9. Market Attractiveness, by Application
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Product Type
    • 13.11.2. By Therapeutic Devices
    • 13.11.3. By Diagnostic & Monitoring Devices
    • 13.11.4. By Application
    • 13.11.5. By Country/Sub-region

14. Latin America Respiratory Devices Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. Therapeutic Devices
    • 14.2.2. Diagnostic & Monitoring Devices
  • 14.3. Market Attractiveness, by Product Type
  • 14.4. Market Value Forecast, by Therapeutic Devices, 2017-2031
    • 14.4.1. Drug Delivery Devices
      • 14.4.1.1. Nebulizers
      • 14.4.1.2. Inhalers
    • 14.4.2. Mechanical Ventilators
      • 14.4.2.1. Invasive
      • 14.4.2.2. Non-invasive
    • 14.4.3. Continuous Positive Airway Pressure
      • 14.4.3.1. Devices
      • 14.4.3.2. Disposables
    • 14.4.4. Resuscitators
      • 14.4.4.1. Reusable
      • 14.4.4.2. Disposables
    • 14.4.5. Humidifiers
    • 14.4.6. Airway Clearance Devices
    • 14.4.7. Oxygen Concentrators
    • 14.4.8. Consumables & Disposables
    • 14.4.9. Others
  • 14.5. Market Attractiveness, by Therapeutic Devices
  • 14.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017-2031
    • 14.6.1. Pulse Oximeters
    • 14.6.2. Capnographs
    • 14.6.3. Spirometers
    • 14.6.4. Polysomnographs
    • 14.6.5. Peak Flow Meters
    • 14.6.6. Gas Analyzers
    • 14.6.7. Others
  • 14.7. Market Attractiveness, by Diagnostic & Monitoring Devices
  • 14.8. Market Value Forecast, by Application, 2017-2031
    • 14.8.1. Chronic Obstructive Pulmonary Disease
    • 14.8.2. Asthma
    • 14.8.3. Obstructive Sleep Apnea
    • 14.8.4. Respiratory Distress Syndrome
    • 14.8.5. Cystic Fibrosis
    • 14.8.6. Pneumonia
  • 14.9. Market Attractiveness, by Application
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Product Type
    • 14.11.2. By Therapeutic Devices
    • 14.11.3. By Diagnostic & Monitoring Devices
    • 14.11.4. By Application
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Respiratory Devices Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2017-2031
    • 15.2.1. Therapeutic Devices
    • 15.2.2. Diagnostic & Monitoring Devices
  • 15.3. Market Attractiveness, by Product Type
  • 15.4. Market Value Forecast, by Therapeutic Devices, 2017-2031
    • 15.4.1. Drug Delivery Devices
      • 15.4.1.1. Nebulizers
      • 15.4.1.2. Inhalers
    • 15.4.2. Mechanical Ventilators
      • 15.4.2.1. Invasive
      • 15.4.2.2. Non-invasive
    • 15.4.3. Continuous Positive Airway Pressure
      • 15.4.3.1. Devices
      • 15.4.3.2. Disposables
    • 15.4.4. Resuscitators
      • 15.4.4.1. Reusable
      • 15.4.4.2. Disposables
    • 15.4.5. Humidifiers
    • 15.4.6. Airway Clearance Devices
    • 15.4.7. Oxygen Concentrators
    • 15.4.8. Consumables & Disposables
    • 15.4.9. Others
  • 15.5. Market Attractiveness, by Therapeutic Devices
  • 15.6. Market Value Forecast, by Diagnostic & Monitoring Devices, 2017-2031
    • 15.6.1. Pulse Oximeters
    • 15.6.2. Capnographs
    • 15.6.3. Spirometers
    • 15.6.4. Polysomnographs
    • 15.6.5. Peak Flow Meters
    • 15.6.6. Gas Analyzers
    • 15.6.7. Others
  • 15.7. Market Attractiveness, by Diagnostic & Monitoring Devices
  • 15.8. Market Value Forecast, by Application, 2017-2031
    • 15.8.1. Chronic Obstructive Pulmonary Disease
    • 15.8.2. Asthma
    • 15.8.3. Obstructive Sleep Apnea
    • 15.8.4. Respiratory Distress Syndrome
    • 15.8.5. Cystic Fibrosis
    • 15.8.6. Pneumonia
  • 15.9. Market Attractiveness, by Application
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Product Type
    • 15.11.2. By Therapeutic Devices
    • 15.11.3. By Diagnostic & Monitoring Devices
    • 15.11.4. By Application
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. ResMed
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Koninklijke Philips N.V.
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Vyaire Medical
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Smiths Medical
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Fisher & Paykel Healthcare Limited
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Dragerwerk AG & Co.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. GE Healthcare
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Getinge AB
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Medtronic plc
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Chart Industries
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview